Disability progression in relapsing MS tends to follow one of four distinct patterns, according to a new study.

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease ...

Fear of relapse and worsening disease is common for MS patients, leading to poorer mental health, per a study calling for ...

Researchers are continuing to explore how the CXCL13-to-BAFF ratio can be used to advance precision medicine for people with multiple sclerosis.

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

“Our data add and expand previous observations on silent progression in MS and are consistent with the view of the disease as a single continuum, in which RAW [relapse-associated worsening] and PIRA ...

Increases in sGFAP during BCDT are linked to disability progression in MS, independent of relapse activity. sGFAP is a stronger predictor of disease progression than sNfL, reflecting different ...

Disability progression independent of relapse activity (PIRA) -- sometimes referred to as silent progression -- is a key integrating concept in the contemporary view of multiple sclerosis (MS). "The ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. An oral brain-penetrant therapeutic delayed the onset of ...

The progression of relapsing-onset multiple sclerosis (MS) and its associated disability may be slowing, results from a large population-based study suggest. In an evaluation of more than 7000 ...

When Derek Stefureac was diagnosed with multiple sclerosis, a chronic disease that affects the central nervous system, he was a smoker who never exercised. Everything changed when he had an "attack" ...